278 related articles for article (PubMed ID: 31950832)
1. IKK-Mediated Regulation of the COP9 Signalosome via Phosphorylation of CSN5.
Zhang J; Zhao R; Yu C; Bryant CLN; Wu K; Liu Z; Ding Y; Zhao Y; Xue B; Pan ZQ; Li C; Huang L; Fang L
J Proteome Res; 2020 Mar; 19(3):1119-1130. PubMed ID: 31950832
[TBL] [Abstract][Full Text] [Related]
2. Downregulation of COP9 signalosome subunits differentially affects the CSN complex and target protein stability.
Peth A; Berndt C; Henke W; Dubiel W
BMC Biochem; 2007 Dec; 8():27. PubMed ID: 18093314
[TBL] [Abstract][Full Text] [Related]
3. Crosstalk between the NF-kappaB activating IKK-complex and the CSN signalosome.
Orel L; Neumeier H; Hochrainer K; Binder BR; Schmid JA
J Cell Mol Med; 2010 Jun; 14(6B):1555-68. PubMed ID: 19656241
[TBL] [Abstract][Full Text] [Related]
4. Endothelial CSN5 impairs NF-κB activation and monocyte adhesion to endothelial cells and is highly expressed in human atherosclerotic lesions.
Asare Y; Shagdarsuren E; Schmid JA; Tilstam PV; Grommes J; El Bounkari O; Schütz AK; Weber C; de Winther MP; Noels H; Bernhagen J
Thromb Haemost; 2013 Jul; 110(1):141-52. PubMed ID: 23636414
[TBL] [Abstract][Full Text] [Related]
5. CSN5/JAB1 suppresses the WNT inhibitor DKK1 in colorectal cancer cells.
Jumpertz S; Hennes T; Asare Y; Schütz AK; Bernhagen J
Cell Signal; 2017 Jun; 34():38-46. PubMed ID: 28229932
[TBL] [Abstract][Full Text] [Related]
6. Role of the COP9 Signalosome (CSN) in Cardiovascular Diseases.
Milic J; Tian Y; Bernhagen J
Biomolecules; 2019 Jun; 9(6):. PubMed ID: 31195722
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of atherogenesis by the COP9 signalosome subunit 5 in vivo.
Asare Y; Ommer M; Azombo FA; Alampour-Rajabi S; Sternkopf M; Sanati M; Gijbels MJ; Schmitz C; Sinitski D; Tilstam PV; Lue H; Gessner A; Lange D; Schmid JA; Weber C; Dichgans M; Jankowski J; Pardi R; de Winther MP; Noels H; Bernhagen J
Proc Natl Acad Sci U S A; 2017 Mar; 114(13):E2766-E2775. PubMed ID: 28292897
[TBL] [Abstract][Full Text] [Related]
8. The COP9 signalosome reduces neuroinflammation and attenuates ischemic neuronal stress in organotypic brain slice culture model.
Tian Y; Milic J; Monasor LS; Chakraborty R; Wang S; Yuan Y; Asare Y; Behrends C; Tahirovic S; Bernhagen J
Cell Mol Life Sci; 2023 Aug; 80(9):262. PubMed ID: 37597109
[TBL] [Abstract][Full Text] [Related]
9. The COP9 signalosome: A versatile regulatory hub of Cullin-RING ligases.
Schulze-Niemand E; Naumann M
Trends Biochem Sci; 2023 Jan; 48(1):82-95. PubMed ID: 36041947
[TBL] [Abstract][Full Text] [Related]
10. Structural and biochemical characterization of the Cop9 signalosome CSN5/CSN6 heterodimer.
Birol M; Enchev RI; Padilla A; Stengel F; Aebersold R; Betzi S; Yang Y; Hoh F; Peter M; Dumas C; Echalier A
PLoS One; 2014; 9(8):e105688. PubMed ID: 25144743
[TBL] [Abstract][Full Text] [Related]
11. Cullin-RING Ligase Regulation by the COP9 Signalosome: Structural Mechanisms and New Physiologic Players.
Rao F; Lin H; Su Y
Adv Exp Med Biol; 2020; 1217():47-60. PubMed ID: 31898221
[TBL] [Abstract][Full Text] [Related]
12. Are Inositol Polyphosphates the Missing Link in Dynamic Cullin RING Ligase Regulation by the COP9 Signalosome?
Zhang X; Rao F
Biomolecules; 2019 Aug; 9(8):. PubMed ID: 31394817
[TBL] [Abstract][Full Text] [Related]
13. Insights into the regulation of the human COP9 signalosome catalytic subunit, CSN5/Jab1.
Echalier A; Pan Y; Birol M; Tavernier N; Pintard L; Hoh F; Ebel C; Galophe N; Claret FX; Dumas C
Proc Natl Acad Sci U S A; 2013 Jan; 110(4):1273-8. PubMed ID: 23288897
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the role of COP9 Signalosome (CSN) subunits in K562; the first link between CSN and autophagy.
Pearce C; Hayden RE; Bunce CM; Khanim FL
BMC Cell Biol; 2009 Apr; 10():31. PubMed ID: 19400951
[TBL] [Abstract][Full Text] [Related]
15. Roles of COP9 signalosome in cancer.
Lee MH; Zhao R; Phan L; Yeung SC
Cell Cycle; 2011 Sep; 10(18):3057-66. PubMed ID: 21876386
[TBL] [Abstract][Full Text] [Related]
16. Crystal structure of the human COP9 signalosome.
Lingaraju GM; Bunker RD; Cavadini S; Hess D; Hassiepen U; Renatus M; Fischer ES; Thomä NH
Nature; 2014 Aug; 512(7513):161-5. PubMed ID: 25043011
[TBL] [Abstract][Full Text] [Related]
17. The COP9 Signalosome: A Multi-DUB Complex.
Dubiel W; Chaithongyot S; Dubiel D; Naumann M
Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32708147
[TBL] [Abstract][Full Text] [Related]
18. Targeted inhibition of the COP9 signalosome for treatment of cancer.
Schlierf A; Altmann E; Quancard J; Jefferson AB; Assenberg R; Renatus M; Jones M; Hassiepen U; Schaefer M; Kiffe M; Weiss A; Wiesmann C; Sedrani R; Eder J; Martoglio B
Nat Commun; 2016 Oct; 7():13166. PubMed ID: 27774986
[TBL] [Abstract][Full Text] [Related]
19. The minimal deneddylase core of the COP9 signalosome excludes the Csn6 MPN- domain.
Pick E; Golan A; Zimbler JZ; Guo L; Sharaby Y; Tsuge T; Hofmann K; Wei N
PLoS One; 2012; 7(8):e43980. PubMed ID: 22956996
[TBL] [Abstract][Full Text] [Related]
20. The COP9 signalosome and its role in plant development.
Schwechheimer C; Isono E
Eur J Cell Biol; 2010; 89(2-3):157-62. PubMed ID: 20036030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
